LEQVIO (Inclisiran)
LEQVIO is an injectable prescription medication used along with diet and other lipid-lowering medicines in adults who need additional lowering of “bad” cholesterol (LDL-C) and have known cardiovascular disease and/or heterozygous familial hypercholesterolemia (HeFH), an inherited condition that causes high levels of LDL-C. It is not known if LEQVIO can decrease problems related to high cholesterol, such as heart attacks or stroke.
Indication:
Adults with Heterozygous familial hypercholesterolemia (HeFH)
Clinical atherosclerotic cardiovascular disease (ASCVD)
Injection Duration:
Frequency:
Loading Dose: 0 and 3 months
Maintenance Dose: Every 6 months